Peptide Blocking CTLA-4 and B7-1 Interaction

Stepan V. Podlesnykh, Kristina E. Abramova, Anastasia Gordeeva, Andrei I. Khlebnikov, Andrei I. Chapoval

Research output: Contribution to journalArticlepeer-review

Abstract

Discovery of the B7 family immune checkpoints such as CTLA-4 (CD152), PD-1 (CD279), as well as their ligands B7-1 (CD80), B7-2 (CD86), B7-H1 (PD-L1, CD274), and B7-DC (PD-L2, CD273), has opened new possibilities for cancer immunotherapy using monoclonal antibodies (mAb). The blockade of inhibitory receptors (CTLA-4 and PD-1) with specific mAb results in the activation of cancer patients' T lymphocytes and tumor rejection. However, the use of mAb in clinics has several limitations including side effects and cost of treatment. The development of new low-molecular compounds that block immune checkpoints' functional activity can help to overcome some of these limitations. In this paper, we describe a synthetic peptide (p344) containing 14 amino acids that specifically interact with CTLA-4 protein. A 3D computer model suggests that this peptide binds to the 99MYPPPY104 loop of CTLA-4 protein and potentially blocks the contact of CTLA-4 receptor with B7-1 ligand. Experimental data confirm the peptide-specific interaction with CTLA-4 and its ability to partially block CTLA-4/B7-1 binding. The identified synthetic peptide can be used for the development of novel immune checkpoint inhibitors that can block CTLA-4 functional activity for cancer immunotherapy.

Original languageEnglish
JournalMolecules (Basel, Switzerland)
Volume26
Issue number2
DOIs
Publication statusPublished - 6 Jan 2021

Keywords

  • cancer
  • immune checkpoints
  • immunotherapy
  • peptide microarray
  • peptides

ASJC Scopus subject areas

  • Analytical Chemistry
  • Chemistry (miscellaneous)
  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery
  • Physical and Theoretical Chemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Peptide Blocking CTLA-4 and B7-1 Interaction'. Together they form a unique fingerprint.

Cite this